3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
21
Rectal Neoplasms
18
Colonic Neoplasms
18
Stomach Neoplasms
13
Gastrointestinal Stromal Tumors
5
Carcinoma, Hepatocellular
5
Pancreatic Neoplasms
3
Liver Neoplasms
3
Peritoneal Neoplasms
2
Neoplastic Cells, Circulating
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Urinary Incontinence
1
Surgical Wound Infection
1
Sexual Dysfunction, Physiological
1
Robotic
1
Pancreatic Neuroendocrine Tumors
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphatic Metastasis
1
Locally Advanced Pancreatic Adenocarcinoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Gemcitabine
61
Cisplatin
39
Oxaliplatin
31
Capecitabine
29
Fluorouracil
22
Leucovorin
20
Irinotecan
12
pembrolizumab
11
130-nm albumin-bound paclitaxel
10
durvalumab
9
Erlotinib Hydrochloride
8
Trastuzumab
7
Bevacizumab
7
Taxes
6
Platinum
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Albumin-Bound Paclitaxel
6
1,2-diaminocyclohexaneplatinum II citrate
6
Specimen Handling
5
Sorafenib
5
Radiotherapy
5
Docetaxel
5
Carboplatin
5
Immunohistochemistry
4
trifluridine tipiracil drug combination
3
dehydroftorafur
3
atezolizumab
3
Watchful Waiting
3
Tegafur
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Neoplasms
×
Laparoscopy
×
Gastrointestinal
×
Clear all
NCT02867865
2025-03-13
POLCAGB
Tata Memorial Hospital
Phase 2/3
Active not recruiting
124 enrolled